Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol for a randomized study assessing the feasibility of home-based albuminuria screening among the general population: The THOMAS study.
van Mil D, Kieneker LM, Evers-Roeten B, Thelen MHM, de Vries H, Hemmelder MH, Dorgelo A, van Etten RW, Heerspink HJL, Gansevoort RT. van Mil D, et al. Among authors: gansevoort rt. PLoS One. 2022 Dec 22;17(12):e0279321. doi: 10.1371/journal.pone.0279321. eCollection 2022. PLoS One. 2022. PMID: 36548281 Free PMC article.
Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study.
Frölke SC, Bouwmans P, Messchendorp AL, Vervoort JPM, Abrahams AC, de Vries APJ, Nieuwkerk PT, Hemmelder MH, Gansevoort RT, Hilbrands LB, Reinders MEJ, Sanders JF, Bemelman FJ, Geerlings SE; RECOVAC Collaborators. Frölke SC, et al. Among authors: gansevoort rt. EClinicalMedicine. 2023 Jul 20;62:102103. doi: 10.1016/j.eclinm.2023.102103. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37533418 Free PMC article.
Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study.
van Mil D, Kieneker LM, Evers-Roeten B, Thelen MHM, de Vries H, Hemmelder MH, Dorgelo A, van Etten RW, Heerspink HJL, Gansevoort RT. van Mil D, et al. Among authors: gansevoort rt. Lancet. 2023 Sep 23;402(10407):1052-1064. doi: 10.1016/S0140-6736(23)00876-0. Epub 2023 Aug 16. Lancet. 2023. PMID: 37597522 Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Prognostic Value of Cardiovascular Biomarkers in the Population.
Neumann JT, Twerenbold R, Weimann J, Ballantyne CM, Benjamin EJ, Costanzo S, de Lemos JA, deFilippi CR, Di Castelnuovo A, Donfrancesco C, Dörr M, Eggers KM, Engström G, Felix SB, Ferrario MM, Gansevoort RT, Giampaoli S, Giedraitis V, Hedberg P, Iacoviello L, Jørgensen T, Kee F, Koenig W, Kuulasmaa K, Lewis JR, Lorenz T, Lyngbakken MN, Magnussen C, Melander O, Nauck M, Niiranen TJ, Nilsson PM, Olsen MH, Omland T, Oskarsson V, Palmieri L, Peters A, Prince RL, Qaderi V, Vasan RS, Salomaa V, Sans S, Smith JG, Söderberg S, Thorand B, Tonkin AM, Tunstall-Pedoe H, Veronesi G, Watanabe T, Watanabe M, Zeiher AM, Zeller T, Blankenberg S, Ojeda F. Neumann JT, et al. Among authors: gansevoort rt. JAMA. 2024 Jun 11;331(22):1898-1909. doi: 10.1001/jama.2024.5596. JAMA. 2024. PMID: 38739396 Free PMC article.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Chronic Kidney Disease Prognosis Consortium; Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Chronic Kidney Disease Prognosis Consortium, et al. Among authors: gansevoort rt. Lancet. 2010 Jun 12;375(9731):2073-81. doi: 10.1016/S0140-6736(10)60674-5. Epub 2010 May 17. Lancet. 2010. PMID: 20483451 Free PMC article.
The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial.
Gansevoort RT, Wheeler DC, Debén FM, Speeckaert M, Thomas D, Berger M, Klein S, Friedrichs F, Paraschin K, Schmieder RE. Gansevoort RT, et al. Nephrol Dial Transplant. 2024 Dec 3:gfae261. doi: 10.1093/ndt/gfae261. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39656628
Serum peroxiredoxin-4, a biomarker of oxidative stress, associates with new-onset chronic kidney disease: A population-based cohort study.
Geertsema S, Geertsema P, Kieneker LM, Abdulle AE, la Bastide-van Gemert S, Bakker SJL, Dullaart RPF, Dijkstra G, Gansevoort RT, Faber KN, van Goor H, Bourgonje AR. Geertsema S, et al. Among authors: gansevoort rt. Redox Biol. 2024 Nov;77:103408. doi: 10.1016/j.redox.2024.103408. Epub 2024 Oct 22. Redox Biol. 2024. PMID: 39490314 Free PMC article.
Baseline, Early Changes, and Residual Albuminuria: Post Hoc Analysis of a Randomized Clinical Trial of Dapagliflozin in Chronic Kidney Disease.
van Mil D, Vart P, Chertow GM, Gansevoort RT, Rossing P, Toto RD, Correa-Rotter R, Langkilde AM, Sjöström CD, Wheeler DC, Heerspink HJL. van Mil D, et al. Among authors: gansevoort rt. Clin J Am Soc Nephrol. 2024 Dec 1;19(12):1574-1584. doi: 10.2215/CJN.0000000000000550. Clin J Am Soc Nephrol. 2024. PMID: 39475817
708 results